Sunil Patel Insider Trading $OMED OncoMed Pharmaceuticals Inc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sunil Patel.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sunil Patel. Sunil Patel is Director in LIGAND PHARMACEUTICALS INC ($LGND) and See Remarks in OncoMed Pharmaceuticals Inc ($OMED) and SVP & Chief Financial Officer in OncoMed Pharmaceuticals Inc ($OMED).

Sunil Patel in OncoMed Pharmaceuticals Inc

Trading Symbol: OMED
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sunil Patel: SVP & Chief Financial Officer, See Remarks
Holdings: 69,538 shares
Current Value: $568,821
Latest Transaction: Jan 08 2018
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Sunil Patel in OncoMed Pharmaceuticals Inc

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, LGND, OMED

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 08 2018	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Option Exercise	A	3.98	100,000	398,000	100,000
Oct 12 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	4.24	1,202	5,099	68,336	69.5 K to 68.3 K (-1.73 %)
Oct 12 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	4.27	46	196	69,538	69.6 K to 69.5 K (-0.07 %)
Oct 10 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Option Exercise	A	4.36	50,000	218,000	50,000
Oct 10 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Grant	A	0.00	25,000	0	69,584	44.6 K to 69.6 K (+56.07 %)
Apr 25 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Option Exercise	A	3.73	60,000	223,800	60,000
Apr 25 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Grant	A	0.00	20,000	0	44,584	24.6 K to 44.6 K (+81.35 %)
Apr 05 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	9.06	5,711	51,731	24,584	30.3 K to 24.6 K (-18.85 %)
Apr 05 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	8.87	43	382	30,295	30.3 K to 30.3 K (-0.14 %)
Jan 05 2017	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Option Exercise	A	7.66	65,000	497,900	65,000
Oct 11 2016	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Grant	A	0.00	12,500	0	30,338	17.8 K to 30.3 K (+70.08 %)
Jan 08 2016	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	21.33	1	21	17,838	17.8 K to 17.8 K (-0.01 %)
Jan 08 2016	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	21.65	69	1,494	17,839	17.9 K to 17.8 K (-0.39 %)
Jan 08 2016	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	22.30	2,092	46,653	17,908	20 K to 17.9 K (-10.46 %)
Dec 29 2015	OMED	OncoMed Pharmaceut ...	Patel Sunil	SVP & Chief Financi ...	Option Exercise	A	21.43	70,000	1,500,100	70,000
Mar 23 2015	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Option Exercise	M	3.42	14,665	50,154	101,595
Mar 23 2015	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Option Exercise	M	3.42	3,335	11,406	116,260
Mar 23 2015	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	27.86	14,665	408,543	20,000	34.7 K to 20 K (-42.30 %)
Mar 23 2015	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Buy	M	3.42	14,665	50,154	34,665	20 K to 34.7 K (+73.33 %)
Mar 23 2015	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Sell	S	27.34	3,335	91,186	20,000	23.3 K to 20 K (-14.29 %)
Mar 23 2015	OMED	OncoMed Pharmaceut ...	Patel Sunil	See Remarks	Buy	M	3.42	3,335	11,406	23,335	20 K to 23.3 K (+16.68 %)

Page: 1